Mesenchymal stromal cells promote or suppress the proliferation of T lymphocytes from cord blood and peripheral blood: The importance of low cell ratio and role of interleukin-6

Cytotherapy

Volumn 11, Issue 5, 2009, Pages 570-583

  Najar, Mehdi ^a   Rouas, Redouane ^a   Raicevic, Gordana ^a   Boufker, Hichame Id ^a   Lewalle, Philippe ^a   Meuleman, Nathalie ^a   Bron, Dominique ^a   Toungouz, Michel ^a   Martiat, Philippe ^a   Lagneaux, Laurence ^a  

^a JULES BORDET INSTITUTE   (Belgium)

Author keywords

Allogeneic T cells; Immunosupportive; Immunosuppressive; Interleukin 6; Mesenchymal stromal cells

Indexed keywords

BROXURIDINE; CARBOXYFLUORESCEIN DIACETATE SUCCINIMIDYL ESTER; CD28 ANTIGEN; CD3 ANTIGEN; INTERLEUKIN 6;

ADULT; ARTICLE; CELL CONTACT; CELL CULTURE; CELL DIFFERENTIATION; CELL POPULATION; CELL PROLIFERATION; CELL VIABILITY; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; UMBILICAL CORD BLOOD;

ADULT; ANTIGENS, CD38; ANTIGENS, CD4; CELL COUNT; CELL PROLIFERATION; CELL SURVIVAL; COCULTURE TECHNIQUES; COLONY-FORMING UNITS ASSAY; CULTURE MEDIA, CONDITIONED; FETAL BLOOD; HUMANS; IMMUNE TOLERANCE; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; INTERLEUKIN-6; INTERLEUKIN-7 RECEPTOR ALPHA SUBUNIT; LYMPHOCYTE ACTIVATION; MESENCHYMAL STEM CELLS; MITOGENS; STROMAL CELLS; T-LYMPHOCYTES; T-LYMPHOCYTES, REGULATORY; YOUNG ADULT;

EID: 70849116391     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1080/14653240903079377     Document Type: Article

References (45)

1. Tondreau T, Meuleman N, Delforge A, Dejeneffe M, Leroy R, Massy M, et al. Mesenchymal stem cells derived froMcD133-positive cells in mobilized peripheral blood and cord blood: Proliferation, Oct4 expression, and plasticity. Stem Cells 2005; 23: 1105-1112
2. Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, et al. Multilineage cells from human adipose tissue: Implications for cell-based therapies. Tissue Eng 2001; 7: 211-228
3. Campagnoli C, Roberts IA, Kumar S, Bennett PR, Bellantuono I, Fisk NM, et al. Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood 2001; 98: 2396-2402.
4. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143-147
5. Keating A. Mesenchymal stromal cells. Curr Opin Hematol. 2006; 13: 419-425
6. Jones BJ, McTaggart SJ. Immunosuppression by mesenchymal stromal cells: From culture to clinic. Exp Hematol 2008; 36: 733-741
7. Di Nicola M, Carlo-Stella C, Magni M, Milanesi M, Longoni PD, Matteucci P, et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecifi c mitogenic stimuli. Blood 2002; 99: 3838-3843
8. Le Blanc K, Tammik L, Sundberg B, Haynesworth SE, Ringden O. Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand J Immunol 2003; 57: 11-20.
9. Krampera M, Glennie S, Dyson J, Scott D, Laylor R, Simpson E, et al. Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specifi c T cells to their cognate peptide. Blood 2003; 101: 3722-3729
10. Nasef A, Ashammakhi N, Fouillard L. Immunomodulatory effect of mesenchymal stromal cells: Possible mechanisms. Regen Med 2008; 3: 531-546
11. Le Blanc K, Tammik C, Rosendahl K, Zetterberg E, Ringden O. HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol 2003; 31: 890-896
12. Ryan JM, Barry F, Murphy JM, Mahon BP. I nterferongamma does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells. Clin Exp Immunol 2007; 149: 353-363
13. Tabera S, Perez-Simon JA, Diez-Campelo M, Sanchez-Abarca LI, Blanco B, Lopez A, et al. The effect of mesenchymal stem cells on the viability, proliferation and differentiation of B-lymphocytes. Haematologica 2008; 93: 1301-1309
14. Corcione A, Benvenuto F, Ferretti E, Giunti D, Cappiello V, Cazzanti F, et al. Human mesenchymal stem cells modulate B-cell functions. Blood 2006; 107: 367-372
15. Rasmusson I, Le Blanc K, Sundberg B, et al. Mesenchymal stem cells stimulate antibody secretion in human B cells. Scand J Immunol 2007; 65: 336-343 (Pubitemid 46481102)
16. Spaggiari GM, Capobianco A, Abdelrazik H, Becchetti F, Mingari MC, Moretta L. Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: Role of indoleamine 2,3-dioxygenase and prostaglandin E2. Blood 2008; 111: 1327-1333
17. +-derived and monocyte-derived dendritic cells. J Immunol 2006; 177: 2080-2087
18. + hemopoietic progenitor cells to differentiate into regulatory dendritic cells through activation of the Notch pathway. J Immunol 2008; 180: 1598-1608
19. Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005; 105: 1815-1822
20. Di Ianni M, Del Papa B, De Ioanni M, Moretti L, Bonifacio E, Cecchini D, et al. Mesenchymal cells recruit and regulate Tregulatory cells. Exp Hematol 2008; 36: 309-318
21. Tondreau T, Lagneaux L, Dejeneffe M, Delforge A, Massy M, Mortier C, et al. Isolation of BM mesenchymal stem cells by plastic adhesion or negative selection: Phenotype, proliferation kinetics and differentiation potential. Cytotherapy 2004; 6: 372-379
22. D'Arena G, Musto P, Cascavilla N, Minervini MM, Di Giorgio G, Maglione A, et al. Inability of activated cord blood Tlymphocytes to perform Th1-like and Th2-like responses: Implications for transplantation. J Hematother Stem Cell Res 1999; 8: 381-385
23. Garcia Vela JA, Delgado I, Bornstein R, Alvarez B, Auray MC, Martin I, et al. Comparative intracellular cytokine production by in vitro stimulated Tlymphocytes from human umbilical cord blood (HUCB) and adult peripheral blood (APB). Anal Cell Pathol 2000; 20: 93-98
24. Han P, McDonald T, Hodge G. Potential immaturity of the T-cell and antigen-presenting cell interaction in cord blood with particular emphasis on the CD40-CD40 ligand costimulatory pathway. Immunology 2004; 113: 26-34.
25. Chadburn A, Inghirami G, Knowles DM. The kinetics and temporaLexpression of T-cell activation-associated antigens CD15 (LeuM1), CD30 (Ki-1), EMA, and CD11c (LeuM5) by benign activated T cells. Hematol Pathol 1992; 6: 193-202.
26. Smol'nikova VV, Voznyuk AV, Potapnev MP. Cytokineinduced differentiation and proliferation of human Tlymphocytes in vitro: Effects of interleukin 2 and interleukin 6. BulLexp Biol Med 2000; 129: 567-570
27. Yonezawa A, Hori T, Sakaida H, Uchiyama T. S DF-1 has costimulatory effects on human T cells: Possible involvement of MAPK (ERK2) activation. Microbiol Immunol 2000; 44: 135-141
28. Djouad F, Plence P, Bony C, Tropel P, Apparailly F, Sany J, et al. Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood 2003; 102: 3837-3844
29. Plumas J, Chaperot L, Richard MJ, Molens JP, Bensa JC, Favrot MC. Mesenchymal stem cells induce apoptosis of activated T cells. Leukemia 2005; 19: 1597-1604
30. Puissant B, Barreau C, Bourin P, Clavel C, Corre J, Bousquet C, et al. Immunomodulatory effect of human adipose tissuederived adult stem cells: Comparison with bone marrow mesenchymal stem cells. Br J Haematol 2005; 129: 118-129
31. Wang XN, Sviland L, Ademokun AJ, Dunn J, Cavanagh G, Proctor SJ, et al. Cellular alloreactivity of human cord blood cells detected by T-cell frequency analysis and a human skin explant model. Transplantation 1998; 66: 903-909
32. Kurtzberg J. U pdate on umbilical cord blood Transplantation. Curr Opin Pediatr. 2009; 21: 22-29
33. Macmillan ML, Blazar BR, Defor TE, Wagner JE. Transplantation of ex-vivo culture-expanded parental haploidentical mesenchymal stem cells to promote engraftment in pediatric recipients of unrelated donor umbilical cord blood: Results of a phase I-II clinical trial. Bone Marrow Transplant 2009; 43: 447-454
34. Harris DT, Schumacher MJ, Locascio J, Besencon FJ, Olson GB, DeLuca D, et al. Phenotypic and functional immaturity of human umbilical cord blood Tlymphocytes. Proc Natl Acad Sci USA 1992; 89: 10006-10010
35. Li C, Zhang W, Jiang X, Mao N. Human-placenta-derived mesenchymal stem cells inhibit proliferation and function of allogeneic immune cells. Cell Tissue Res 2007; 330: 437-446
36. Fang L, Lange C, Engel M, Zander AR, Fehse B. Sensitive balance of suppressing and activating effects of mesenchymal stem cells on T-cell proliferation. Transplantation 2006; 82: 1370-1373
37. Rasmusson I, Ringden O, Sundberg B, Le Blanc K. Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms. Exp Cell Res 2005; 305: 33-41.
38. Tse WT, Pendleton JD, Beyer WM, Egalka MC, Guinan EC. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: Implications in transplantation. Transplantation 2003; 75: 389-397
39. Krampera M, Cosmi L, Angeli R, Pasini A, Liotta F, Andreini A, et al. Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells. Stem Cells 2006; 24: 386-398
40. Chan JL, Tang KC, Patel AP, Bonilla LM, Pierobon N, Ponzio NM, et al. Antigen-presenting property of mesenchymal stem cells occurs during a narrow window at low levels of interferon-gamma. Blood 2006; 107: 4817-4824.
41. Magatti M, De Munari S, Vertua E, Gibelli L, Wengler GS, Parolini O. Human amnion mesenchyme harbors cells witHallogeneic T-cell suppression and stimulation capabilities. Stem Cells 2008; 26: 182-192
42. Eddahri F, Denanglaire S, Bureau F, Spolski R, Leonard WJ, Leo O, et al. Interleukin-6/STAT3 signaling regulates the ability of naive T cells to acquire B-cell help capacities. Blood 2009; 113: 2426-2433
43. Traggiai E, Volpi S, Schena F, Gattorno M, Ferlito F, Moretta L, et al. Bone marrow-derived mesenchymal stem cells induce both polyclonaLexpansion and differentiation of B cells isolated from healthy donors and systemic lupus erythematosus patients. Stem Cells 2008; 26: 562-569
44. + regulatory T cells. Stem Cells 2008; 26: 212-222
45. Barrett AJ, Le Blanc K. Prophylaxis of acute GVHD: Manipulate the graft or the environment? Best Pract Res Clin Haematol 2008; 21: 165-176